openPR Logo
Press release

Chemiluminescence Immunoassay (CLIA) Analyzers on the Rise Due to Increased Disease Prevalence and Technological Advancements

10-28-2024 12:56 PM CET | Health & Medicine

Press release from: Emergen Research

Chemiluminescence Immunoassay (CLIA) Analyzers Market

Chemiluminescence Immunoassay (CLIA) Analyzers Market

The global Chemiluminescence Immunoassay (CLIA) analyzers market size was USD 5.42 Billion in 2022 and is expected to register rapid revenue CAGR of 6.0% during the forecast period. The market for Chemiluminescence Immunoassay (CLIA) analyzers is experiencing significant growth, driven by the rising prevalence of chronic and acute diseases alongside advancements in technology. These specialized devices are designed to measure the formation of antigen-antibody complexes through the emission of light, playing a crucial role in diagnosing various conditions, including endocrine disorders, infectious diseases, and cancers.

Market Drivers

One of the primary factors propelling the growth of the CLIA analyzer market is the increasing incidence of chronic diseases such as cancer and heart disease. In 2020, cancer was responsible for approximately 10 million deaths worldwide, accounting for one in six deaths. The most common cancers include those of the breast, lungs, colon, and prostate. Infections linked to cancer, like hepatitis and Human Papillomavirus (HPV), also contribute significantly, especially in low-income countries.

The ability of CLIA analyzers to provide accurate diagnoses and monitor treatment progress is vital. Early detection of many cancers can lead to effective treatment and better patient outcomes. Research has shown that CLIA methods can reliably diagnose conditions, such as Alzheimer's disease, demonstrating their growing importance in medical research and diagnostics.

To avail Sample Copy of the report @https://www.emergenresearch.com/request-sample/2570

Market Developments

The demand for CLIA analyzers is being fueled by the introduction of innovative models that offer faster and more precise results. These devices are characterized by high throughput, automation, and advanced connectivity, making them efficient tools for clinical laboratories. Multiplexing capabilities allow multiple analytes to be analyzed simultaneously from a single sample, reducing both time and costs. The trend towards high-throughput testing is particularly evident in busy clinical environments, where efficiency is paramount.

Market Restraints

Despite the positive outlook, there are challenges facing the CLIA analyzer market. A shortage of qualified personnel and strict regulatory requirements could hinder growth. The training needed for laboratory technicians often spans five to ten years, leading to an aging workforce and fewer new entrants into the field. A recent study estimates a potential shortage of over 400,000 home health aides and nearly 30,000 nurse practitioners in Europe by 2025.

Furthermore, the high initial investment and maintenance costs associated with CLIA analyzers can be a barrier, particularly in developing nations like Brazil, South Africa, and India, where budgets for healthcare equipment are limited.

Market Trends

The market is also witnessing a trend toward next-generation integrated immunoassays. For instance, Abbott recently received FDA clearance for its Alinity ci-series analyzers, which enhance clinical chemistry and immunoassay diagnostics. Companies like Danaher (Beckman Coulter) are continuously advancing their offerings, with recent approvals for new immunoassays to measure hormones and other important biomarkers.

Request Customization In The Report @https://www.emergenresearch.com/request-for-customization/2570

Market Segmentation Insights

The global CLIA analyzers market is segmented based on type, product, and end-use. In terms of type, high-throughput analyzers are leading the market due to their ability to handle large volumes of samples efficiently. For example, Abbott's Architect 12000SR can perform 200 tests per hour.

Product-wise, the reagent segment is expected to grow steadily due to the lower costs and faster testing times associated with reagents used in CLIA analyzers. Additionally, the consumables segment will likely capture significant market share as laboratories increasingly require various materials and kits for operations.

From an end-use perspective, hospitals and clinical laboratories are poised for moderate revenue growth, driven by a surge in patient visits due to infectious diseases and cancers. These facilities rely heavily on CLIA analyzers for a wide range of diagnostic tests, including those for autoimmune diseases and thyroid function.

Chemiluminescence Immunoassay Analyzers Top Companies and Competitive Landscape

The global CLIA analyzers market is fairly fragmented with many large and medium-sized players accounting for majority of market revenue. Major players are deploying various strategies, entering into mergers & acquisitions, strategic agreements & contracts, developing, testing, and introducing more effective CLIA analyzers solutions.

Some major players included in the global Chemiluminescence Immunoassay (CLIA) analyzers market report are:

Hoffmann-La Roche AG

Shenzhen Mindray Bio-Medical Electronics Co., Ltd.

Siemens Healthineers AG

Danaher Corporation

Beckman Coulter Inc.

DiaSorin S.p.A.

Sysmex Corporation

Randox Laboratories Ltd.

Tosoh Corporation

Shenzhen New Industries Biomedical Engineering Co., Ltd.

bioMerieux SA

Abbott Laboratories

Johnson & Johnson

Ortho Clinical Diagnostics

Quidel Corporation

Browse The Full Chemiluminescence Immunoassay Analyzers Market Report Description, Along With The Tocs And List Of Facts And Figures @ https://www.emergenresearch.com/industry-report/chemiluminescence-immunoassay-analyzers-market

Chemiluminescence Immunoassay (CLIA) Analyzers Latest Industry Updates

In April 2020, Accelerate Diagnostics, Inc. and BioCheck, Inc. signed a strategic distribution agreement for CLIA products. According to the terms of this agreement, Accelerate will set up BioCheck's MS-FAST system, a fully automated Chemiluminescence Immunoassay (CLIA) analyzer, and BioCheck's SARS-CoV-2 assays for the detection of IgM and IgG antibodies.

In December 2020, Siemens Healthineers launched its Atellica solution immunoassay analyzers for high-volume testing in clinical laboratories.

Chemiluminescence Immunoassay (CLIA) Analyzers Market Segmentation Analysis

For the purpose of this report, Emergen Research has segmented the global Chemiluminescence Immunoassay (CLIA) analyzers market on the basis of type, application, product, end-use, and region:

Type Outlook (Revenue, USD Billion; 2019-2032)

High Throughput

Medium Throughput

Low Throughput

Application Outlook (Revenue, USD Billion; 2019-2032)

Endocrine Disorders

Oncology

Infectious Diseases

Hepatitis and Retrovirus

Cardiovascular Disorders

Allergy

Autoimmunity

Drug Discovery and Development

Others

Product Outlook (Revenue, USD Billion; 2019-2032)

Analyzers

Automated

Semi-automated

Reagents

Luminophore Markets

Enzymatic Markets

Consumables

End-use Outlook (Revenue, USD Billion; 2019-2032)

Hospitals & Clinics

Pharmaceutical and Biotechnology Companies

Others

Regional Outlook (Revenue, USD Billion; 2019-2032)

North America

U.S.

Canada

Europe

Germany

France

UK

Italy

Spain

Benelux

Russia

Rest of Europe

Asia Pacific

China

Japan

South Korea

India

ASEAN Countries

Oceania

Rest of APAC

Latin America

Brazil

Mexico

Rest of LATAM

Middle East & Africa

GCC Countries

Israel

Turkey

South Africa

Rest of Middle East & Africa

Click Here To Buy Now @https://www.emergenresearch.com/select-license/2570

Latest Published Reports by Emergen Research:

Chemiluminescence Immunoassay (CLIA) Analyzers Market Size @ https://www.emergenresearch.com/industry-report/chemiluminescence-immunoassay-analyzers-market/market-size

Chemiluminescence Immunoassay (CLIA) Analyzers Market Share @ https://www.emergenresearch.com/industry-report/chemiluminescence-immunoassay-analyzers-market/market-share

Chemiluminescence Immunoassay (CLIA) Analyzers Market Trends @ https://www.emergenresearch.com/industry-report/chemiluminescence-immunoassay-analyzers-market/market-trends

Chemiluminescence Immunoassay (CLIA) Analyzers Regional Market Demand @ https://www.emergenresearch.com/industry-report/chemiluminescence-immunoassay-analyzers-market/regional-market-demand

Chemiluminescence Immunoassay (CLIA) Analyzers Market Analysis @ https://www.emergenresearch.com/industry-report/chemiluminescence-immunoassay-analyzers-market/market-analysis

Contact Us:
Eric Lee
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com
Visit for More Insights: https://www.emergenresearch.com/insights

Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyse consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Chemiluminescence Immunoassay (CLIA) Analyzers on the Rise Due to Increased Disease Prevalence and Technological Advancements here

News-ID: 3712270 • Views:

More Releases from Emergen Research

Global Internet of Things (IoT) in Healthcare Market to Reach USD 299.05 Billion in 2023, Set for Strong Growth at 16.5% CAGR
Global Internet of Things (IoT) in Healthcare Market to Reach USD 299.05 Billion …
The global Internet of Things (IoT) in Healthcare Market was valued at USD 299.05 billion in 2023 and is expected to grow at a CAGR of 16.5% during the forecast period. This growth is fueled by the rising use of connected healthcare devices, increasing demand for early disease detection through remote monitoring, and growing adoption of artificial intelligence (AI) tools within IoT-based healthcare systems. The market is also benefiting from the
Global Stem Cell Therapy Market to Reach USD 49.2 Billion by 2034, Growing at 13.6% CAGR
Global Stem Cell Therapy Market to Reach USD 49.2 Billion by 2034, Growing at 13 …
The global Stem Cell Therapy Market, valued at USD 13.7 billion in 2024, is projected to reach USD 49.2 billion by 2034, expanding at a compound annual growth rate (CAGR) of 13.6%. Growth is being fueled by the rising burden of chronic diseases, rapid progress in cell-based studies, and increasing investments in regenerative medicine and personalized healthcare solutions. Stem cell therapies offer the ability to repair, replace, or restore damaged tissues
Artificial Intelligence Strengthens Cybersecurity as Threats Grow More Sophisticated
Artificial Intelligence Strengthens Cybersecurity as Threats Grow More Sophistic …
The global Artificial Intelligence in cybersecurity market size was USD 23.8 Billion in 2023 and is expected to reach a market valuation of USD 29.44 billion by the end of 2024 registering a CAGR of 23.7% during the forecast period. The adoption of Artificial Intelligence (AI) in cybersecurity is rapidly gaining traction as organizations worldwide face increasingly complex and frequent cyber threats. By combining advanced technologies such as Machine Learning
Global Regenerative Medicine Market to Reach USD 125.6 Billion by 2034, Growing at 13.9% CAGR
Global Regenerative Medicine Market to Reach USD 125.6 Billion by 2034, Growing …
The global regenerative medicine market, valued at USD 34.2 billion in 2024, is set to grow to USD 125.6 billion by 2034, expanding at a compound annual growth rate (CAGR) of 13.9%. Growth is being fueled by rising approvals of advanced therapies, strong demand for personalized treatments in cancer and orthopedics, and expanding cell and gene therapy manufacturing across major markets such as North America, Europe, and Asia. Once seen as

All 5 Releases


More Releases for CLIA

Rising Demand for Accurate Diagnostics Propels Global Chemiluminescence Immunoas …
Transparency Market Research, a leading provider of market intelligence, has released a comprehensive report detailing the dynamics of the global Chemiluminescence Immunoassay (CLIA) Analyzers Market. The report, covering the historical period of 2017-2018 and forecasting trends up to 2027, underscores the market's potential growth, attributing it to several key factors. Request Sample of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=31517 According to the report, the global CLIA analyzers market was valued at US$ 5.04 billion in
Chemiluminescence Immunoassay (CLIA) Analyzers Market to Reach US$ 8.69 bn by 20 …
The latest research study released by Transparency Market Research on "Chemiluminescence Immunoassay (CLIA) Analyzers Market Forecast to 2017-2025 ″ research provides accurate economic, global, and country-level predictions and analyses. It provides a comprehensive perspective of the competitive market as well as an in-depth supply chain analysis to assist businesses in identifying major changes in industry practices. The market report also examines the current state of the Chemiluminescence Immunoassay (CLIA) Analyzers
Insulin CLIA Kit Market Analysis,Demand,Trends and Forecast 2029
Global Info Research announces the release of the report "Global Insulin CLIA Kit Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029" . The report is a detailed and comprehensive analysis presented by region and country, type and application. As the market is constantly changing, the report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets.
Chemiluminescence Immunoassay (CLIA) Market - Bringing Clarity to Diagnosis: Tra …
Newark, New Castle, USA - new report, titled Chemiluminescence Immunoassay (CLIA) Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Chemiluminescence Immunoassay (CLIA) market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Chemiluminescence Immunoassay (CLIA) market. The report offers an overview of
Chemiluminescence Immunoassay (CLIA) Analyzers Market Size to Observe Steady Gro …
According to a Transparency Market Research (TMR) research report, the global chemiluminescence immunoassay (clia) analyzers market is expected to reach US$ 8.69 Bn by the end of 2025. This suggests that the market is likely to expand at a CAGR of 6.3% during the forecast period, 2017 to 2025. The business intelligence study on the market is prepared by employing industry-validated primary and secondary methods. The study uses these to collect
Chemiluminescence Immunoassay (CLIA) Analyzers Market Scope and Opportunities An …
The "Global Chemiluminescence Immunoassay (CLIA) Analyzers Market Analysis to 2028" is a specialized and in-depth study of the food and beverages industry with a special focus on the global market trend analysis. The report aims to provide an overview of the Chemiluminescence Immunoassay (CLIA) Analyzers market with detailed market segmentation by products, applications, end user and geography. The report provides key statistics on the market status of the leading Chemiluminescence